137 related articles for article (PubMed ID: 20654247)
1. [Expression of E-cadherin and beta-catenin in oral squamous cell carcinomas of tongue: correlation with the clinicopathologic features and patient prognosis].
Zhu R; Jiang XY; Song XL; Zhang W; Chen S; Liu LK
Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 May; 45(5):295-8. PubMed ID: 20654247
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin and β-catenin expression in well-differentiated and moderately-differentiated oral squamous cell carcinoma: relations with clinical variables.
Rosado P; Lequerica-Fernández P; Fernández S; Allonca E; Villallaín L; de Vicente JC
Br J Oral Maxillofac Surg; 2013 Mar; 51(2):149-56. PubMed ID: 22525043
[TBL] [Abstract][Full Text] [Related]
4. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
[TBL] [Abstract][Full Text] [Related]
5. Decreased E-cadherin but not beta-catenin expression is associated with vascular invasion and decreased survival in head and neck squamous carcinomas.
Kurtz KA; Hoffman HT; Zimmerman MB; Robinson RA
Otolaryngol Head Neck Surg; 2006 Jan; 134(1):142-6. PubMed ID: 16399195
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of β-catenin and E-cadherin is correlated with poor prognosis of nasopharyngeal cancer.
Xu L; Jiang Y; Zheng J; Xie G; Li J; Shi L; Fan S
Hum Pathol; 2013 Jul; 44(7):1357-64. PubMed ID: 23375645
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of SIP1 and downregulation of E-cadherin predict delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma after partial glossectomy.
Sakamoto K; Imanishi Y; Tomita T; Shimoda M; Kameyama K; Shibata K; Sakai N; Ozawa H; Shigetomi S; Fujii R; Fujii M; Ogawa K
Ann Surg Oncol; 2012 Feb; 19(2):612-9. PubMed ID: 21913013
[TBL] [Abstract][Full Text] [Related]
8. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
Tang XJ; Zhou QH; Zhang SF; Liu LX
Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
[TBL] [Abstract][Full Text] [Related]
9. Significance of E-cadherin, β-catenin, and vimentin expression as postoperative prognosis indicators in cervical squamous cell carcinoma.
Cheng Y; Zhou Y; Jiang W; Yang X; Zhu J; Feng D; Wei Y; Li M; Yao F; Hu W; Xiao W; Ling B
Hum Pathol; 2012 Aug; 43(8):1213-20. PubMed ID: 22221700
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.
Ozgüven BY; Karaçetin D; Kabukçuoğlu F; Taşkin T; Yener Ş
Pol J Pathol; 2011; 62(1):19-24. PubMed ID: 21574102
[TBL] [Abstract][Full Text] [Related]
11. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
[TBL] [Abstract][Full Text] [Related]
12. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY
Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome.
Liu LK; Jiang XY; Zhou XX; Wang DM; Song XL; Jiang HB
Mod Pathol; 2010 Feb; 23(2):213-24. PubMed ID: 19915524
[TBL] [Abstract][Full Text] [Related]
14. Combined loss of E-cadherin and aberrant β-catenin protein expression correlates with a poor prognosis for small intestinal adenocarcinomas.
Lee HJ; Lee OJ; Jang KT; Bae YK; Chung JY; Eom DW; Kim JM; Yu E; Hong SM
Am J Clin Pathol; 2013 Feb; 139(2):167-76. PubMed ID: 23355201
[TBL] [Abstract][Full Text] [Related]
15. β-Catenin and E-cadherin expression in stage I adult-type granulosa cell tumour of the ovary: correlation with tumour morphology and clinical outcome.
Stewart CJ; Doherty D; Guppy R; Louwen K; Leung YC
Histopathology; 2013 Jan; 62(2):257-66. PubMed ID: 22958082
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract.
Kashibuchi K; Tomita K; Schalken JA; Kume H; Yamaguchi T; Muto S; Horie S; Kitamura T
Eur Urol; 2006 May; 49(5):839-45; discussion 845. PubMed ID: 16426728
[TBL] [Abstract][Full Text] [Related]
17. Changes in immunoexpression of E-cadherin and beta-catenin in oral squamous cell carcinoma with and without nodal metastasis.
Lopes FF; da Costa Miguel MC; Pereira AL; da Cruz MC; de Almeida Freitas R; Pinto LP; de Souza LB
Ann Diagn Pathol; 2009 Feb; 13(1):22-9. PubMed ID: 19118778
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.
Voutilainen KA; Anttila MA; Sillanpää SM; Ropponen KM; Saarikoski SV; Juhola MT; Kosma VM
J Clin Pathol; 2006 May; 59(5):460-7. PubMed ID: 16461565
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of the clinicopathological significance of E-cadherin and catenins (alpha, beta, gamma) expression in the surgical management of oral tongue carcinoma.
Chow V; Yuen AP; Lam KY; Tsao GS; Ho WK; Wei WI
J Cancer Res Clin Oncol; 2001 Jan; 127(1):59-63. PubMed ID: 11206273
[TBL] [Abstract][Full Text] [Related]
20. Altered E-cadherin/beta-catenin expression in oral squamous carcinoma with and without nodal metastasis.
Mahomed F; Altini M; Meer S
Oral Dis; 2007 Jul; 13(4):386-92. PubMed ID: 17577324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
